Can Inhibitor-Resistant Substitutions in the Mycobacterium tuberculosis β-Lactamase BlaC Lead to Clavulanate Resistance?: a Biochemical Rationale for the Use of β-Lactam–β-Lactamase Inhibitor Combinations
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Can Inhibitor-Resistant Substitutions in the Mycobacterium tuberculosis β-Lactamase BlaC Lead to Clavulanate Resistance?: a Biochemical Rationale for the Use of β-Lactam–β-Lactamase Inhibitor Combinations
Authors
Keywords
-
Journal
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 57, Issue 12, Pages 6085-6096
Publisher
American Society for Microbiology
Online
2013-09-24
DOI
10.1128/aac.01253-13
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Understanding the Molecular Determinants of Substrate and Inhibitor Specificities in the Carbapenemase KPC-2: Exploring the Roles of Arg220 and Glu276
- (2012) Krisztina M. Papp-Wallace et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Meropenem/Clavulanate and Linezolid Treatment for Extensively Drug-resistant Tuberculosis
- (2011) Nicolas Dauby et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- PHENIX: a comprehensive Python-based system for macromolecular structure solution
- (2010) Paul D. Adams et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Substrate Selectivity and a Novel Role in Inhibitor Discrimination by Residue 237 in the KPC-2 -Lactamase
- (2010) K. M. Papp-Wallace et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Structures of the Michaelis Complex (1.2 Å) and the Covalent Acyl Intermediate (2.0 Å) of Cefamandole Bound in the Active Sites of theMycobacterium tuberculosisβ-Lactamase K73A and E166A Mutants,
- (2010) Lee W. Tremblay et al. BIOCHEMISTRY
- Biochemical and Structural Characterization ofMycobacterium tuberculosisβ-Lactamase with the Carbapenems Ertapenem and Doripenem
- (2010) Lee W. Tremblay et al. BIOCHEMISTRY
- Three Decades of -Lactamase Inhibitors
- (2010) S. M. Drawz et al. CLINICAL MICROBIOLOGY REVIEWS
- Mechanistic Basis for the Emergence of Catalytic Competence against Carbapenem Antibiotics by the GES Family of β-Lactamases
- (2009) Hilary Frase et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Different Intermediate Populations Formed by Tazobactam, Sulbactam, and Clavulanate Reacting with SHV-1 β-Lactamases: Raman Crystallographic Evidence†
- (2009) Matthew Kalp et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Analysis of the plasticity of location of the Arg244 positive charge within the active site of the TEM-1 β-lactamase
- (2009) David C. Marciano et al. PROTEIN SCIENCE
- Meropenem-Clavulanate Is Effective Against Extensively Drug-Resistant Mycobacterium tuberculosis
- (2009) J.-E. Hugonnet et al. SCIENCE
- Structure of the Covalent Adduct Formed between Mycobacterium tuberculosis β-Lactamase and Clavulanate†‡
- (2008) Lee W. Tremblay et al. BIOCHEMISTRY
- GROMACS 4: Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation
- (2008) Berk Hess et al. Journal of Chemical Theory and Computation
- Inhibition of Class A β-Lactamases by Carbapenems: Crystallographic Observation of Two Conformations of Meropenem in SHV-1
- (2008) Michiyosi Nukaga et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Genome-wide regulon and crystal structure of BlaI (Rv1846c) fromMycobacterium tuberculosis
- (2008) Claudia Sala et al. MOLECULAR MICROBIOLOGY
- PDBsum new things
- (2008) R. A. Laskowski NUCLEIC ACIDS RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search